A Role for VEGFR2 Activation in Endothelial Responses Caused by Barrier Disruptive OxPAPC Concentrations

• Anna A. Birukova ,

  Contributed equally to this work with: Anna A. Birukova, Sangderk Lee

  Affiliation Section of Pulmonary and Critical Medicine, Department of Medicine, Lung Injury Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Sangderk Lee ,

  Contributed equally to this work with: Anna A. Birukova, Sangderk Lee

  Affiliation Departments of Pathology and Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Vitaliy Starosta,

  Affiliation Section of Pulmonary and Critical Medicine, Department of Medicine, Lung Injury Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Tinghuai Wu,

  Affiliation Section of Pulmonary and Critical Medicine, Department of Medicine, Lung Injury Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Tiffany Ho,

  Affiliation Departments of Pathology and Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Jin Kim,

  Affiliation Departments of Pathology and Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Judith A. Berliner,

  Affiliation Departments of Pathology and Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Konstantin G. Birukov

  * E-mail: kbirukov@medicine.bsd.uchicago.edu

  Affiliation Section of Pulmonary and Critical Medicine, Department of Medicine, Lung Injury Center, University of Chicago, Chicago, Illinois, United States of America

  ⨯